Richard Ayikpoe

Merck & Co., Inc., Rahway, NJ, USA (United States)

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Peptide backbone modifications in lanthipeptides”.

Peptide backbone modifications in lanthipeptides

Methods in enzymology on CD-ROM/Methods in enzymology(2021)10.1016/bs.mie.2021.04.012

N/A

0DataRank · unranked

15 citations

Wilfred A. van der Donk, Richard Ayikpoe

A scalable platform to discover antimicrobials of ribosomal origin

Nature Communications(2022)10.1038/s41467-022-33890-w

N/A

0DataRank · unranked

105 citations

Chengyou Shi, Alexander J. Battiste, Sara M. Eslami, Sangeetha Ramesh, Max A. Simon +14 more

Macrocyclization and Backbone Rearrangement During RiPP Biosynthesis by a SAM-Dependent Domain-of-Unknown-Function 692

ACS Central Science(2023)10.1021/acscentsci.3c00160

N/A

0DataRank · unranked

56 citations

Lingyang Zhu, Jeff Y. Chen, Chi P. Ting, Wilfred A. van der Donk, Richard Ayikpoe

A remarkable transformation catalyzed by a domain-of-unknown-function 692 during the biosynthesis of a new RiPP natural product

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.02.06.527370

N/A

0DataRank · unranked

0 citations

Lingyang Zhu, Jeff Y. Chen, Chi P. Ting, Wilfred A. van der Donk, Richard Ayikpoe